financetom
Business
financetom
/
Business
/
Update: CenterPoint Energy Faces Probe for Potential Violations During Hurricane, Texas Official Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: CenterPoint Energy Faces Probe for Potential Violations During Hurricane, Texas Official Says
Aug 12, 2024 1:01 PM

03:38 PM EDT, 08/12/2024 (MT Newswires) -- (Updates with CenterPoint Energy ( CNP ) comment in the third paragraph.)

CenterPoint Energy ( CNP ) faces a probe for potential violations of Texas laws for its conduct during Hurricane Beryl, Ken Paxton, the state's attorney general, said Monday.

The investigation involves allegations of "fraud, waste, and improper use of taxpayer-provided funds," Paxton said in a statement. The company's conduct may have caused "significant harm" to Houston residents through outages, rate increases, and delays in restoring power" during the hurricane, Paxton said.

"Since Hurricane Beryl, we have demonstrated our absolute commitment to transparency and cooperation through our participation in three separate hearings at the Public Utility Commission of Texas, the Senate, and the House," CenterPoint Energy ( CNP ) spokesperson John Sousa said in an email to MT Newswires. "We look forward to cooperating with the Texas attorney general or any other agency and have made clear our commitment to upholding the values of our company."

The company's shares fell 1.5% in recent trading Monday.

Price: 26.09, Change: -0.38, Percent Change: -1.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Monte Rosa Therapeutics Signs Supply Deal With Johnson & Johnson for Phase 2 Prostate Cancer Study
Monte Rosa Therapeutics Signs Supply Deal With Johnson & Johnson for Phase 2 Prostate Cancer Study
Mar 16, 2026
08:13 AM EDT, 03/16/2026 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) said Monday it has entered a clinical supply agreement with Johnson & Johnson ( JNJ ) to evaluate investigational drug MRT-2359 in combination with Erleada in patients with metastatic castration-resistant prostate cancer with androgen receptor mutations. Under the agreement, Monte Rosa Therapeutics ( GLUE ) will sponsor...
CytomX Therapeutics Details Phase 1 Trial Results For Colorectal Cancer Treatment
CytomX Therapeutics Details Phase 1 Trial Results For Colorectal Cancer Treatment
Mar 16, 2026
08:12 AM EDT, 03/16/2026 (MT Newswires) -- CytomX Therapeutics ( CTMX ) said Monday a Phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%. Patients receiving the 10-milligram per kilogram dose demonstrated an estimated median progression-free survival of 7.1 months, the company said. The 8.6-milligram per kilogram cohort...
Citi to keep most UAE branches closed indefinitely due to Iran war
Citi to keep most UAE branches closed indefinitely due to Iran war
Mar 16, 2026
DUBAI, March 16 - Citigroup ( C ) is keeping most branches and offices in the UAE closed until further notice after temporarily closing them last week, the bank said on Monday, the latest sign of the impact on the industry of the Iran war. Now in its third week, the U.S.-Israeli war on Iran has so far killed at...
Form 8.3
Form 8.3
Mar 16, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved